Bio-Gate AG (FRA:BIG)
Germany · Delayed Price · Currency is EUR 2.875
+0.020 (0.70%)
At close: Aug 5, 2026
Bio-Gate AG Financials Overview
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 7.74 | 7.74 | 7.09 | 7.31 | 6.11 | 6.43 |
Revenue Growth | 10.69% | 9.15% | -2.96% | 19.52% | -4.86% | 24.44% |
Gross Profit Gross Profit Growth | 4.31 | 4.31 | 4.14 | 3.88 | 3.58 | 3.83 |
Operating Income Operating Income Growth | -1.13 | -1.13 | -1.6 | -1.59 | -1.78 | -0.54 |
Net Income Net Income Growth | -1.16 | -1.16 | -1.62 | -1.62 | -1.81 | -0.54 |
Earnings Per Share EPS Growth | -0.57 | -0.57 | -0.90 | -0.95 | -1.15 | -0.35 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Medical Technology Medical Technology Growth | 0.85 | 0.85 | 0.7 | 0.46 | 0.65 | 0.45 |
Industry and Hygiene Industry and Hygiene Growth | 0.19 | 0.19 | 0.17 | 0.32 | 0.45 | 0.43 |
Dermacosmetics and Wound Care Dermacosmetics and Wound Care Growth | 2.9 | 2.9 | 3.64 | 3.93 | 2.9 | 3.66 |
Measurement Services Measurement Services Growth | 0.68 | 0.68 | 0.62 | 0.53 | 0.44 | 0.67 |
Veterinary Veterinary Growth | 2.78 | 2.78 | 1.93 | 2.01 | 1.55 | 1.02 |
Total Total Growth | 7.4 | 7.4 | 7.05 | 7.25 | 5.99 | 6.24 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 0.7 | 0.7 | 0.3 | 1.33 | 1.61 | 1.97 |
Total Debt Total Debt Growth | 0.86 | 0.86 | 0.43 | 0.42 | 0.42 | 0.46 |
Net Cash (Debt) Net Cash Growth | -0.16 | -0.16 | -0.13 | 0.91 | 1.19 | 1.51 |
Net Cash Growth | - | - | - | -23.39% | -21.26% | 352.90% |
Net Cash Per Share Net Cash Per Share Growth | -0.08 | -0.08 | -0.07 | 0.53 | 0.76 | 0.97 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -1.01 | -1.01 | -1.22 | -0.98 | -2.15 | -0.63 |
Capital Expenditures CapEx Growth | -0.03 | -0.03 | -0.05 | -0.08 | -0.26 | -0.27 |
Free Cash Flow Free Cash Flow Growth | -1.04 | -1.04 | -1.27 | -1.06 | -2.42 | -0.91 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 55.65% | 55.65% | 58.32% | 53.08% | 58.55% | 59.57% |
Operating Margin | -14.58% | -14.58% | -22.63% | -21.79% | -29.18% | -8.35% |
Pretax Margin | -15.75% | -15.75% | -23.47% | -22.47% | -29.61% | -8.74% |
Profit Margin | -15.05% | -15.05% | -22.87% | -22.20% | -29.54% | -8.47% |
FCF Margin | -13.41% | -13.41% | -17.86% | -14.52% | -39.57% | -14.12% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 0.75 | 1.03 | 0.97 | 1.22 | 3.40 | 4.54 |